CIK 1906594
China Universal Asset Management Co., Ltd.
Institutional 13F holdings & portfolio
Holdings
497
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
4
Holdings
13F filings as of Dec 31, 2025 · Showing 301–350 of 497
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| KNSA | KINIKSA PHARMACEUTICALS INTE | 7K | $100K–$500K | SH |
| HTHT | H WORLD GROUP LTD-ADR | 6K | $100K–$500K | SH |
| LEGN | LEGEND BIOTECH CORP-ADR | 14K | $100K–$500K | SH |
| SNDX | SYNDAX PHARMACEUTICALS INC | 14K | $100K–$500K | SH |
| VCEL | VERICEL CORP | 8K | $100K–$500K | SH |
| HROW | HARROW INC | 6K | $100K–$500K | SH |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 19K | $100K–$500K | SH |
| GMAB | GENMAB A/S -SP ADR | 10K | $100K–$500K | SH |
| HLT | HILTON WORLDWIDE HOLDINGS IN | 1K | $100K–$500K | SH |
| GLUE | MONTE ROSA THERAPEUTICS INC | 19K | $100K–$500K | SH |
| PHVS | PHARVARIS NV | 10K | $100K–$500K | SH |
| ANIP | ANI PHARMACEUTICALS INC | 4K | $100K–$500K | SH |
| SEPN | SEPTERNA INC | 10K | $100K–$500K | SH |
| OMER | OMEROS CORP | 17K | $100K–$500K | SH |
| MNKD | MANNKIND CORP | 50K | $100K–$500K | SH |
| DGX | QUEST DIAGNOSTICS INC | 2K | $100K–$500K | SH |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 34K | $100K–$500K | SH |
| ALVO | ALVOTECH SA | 51K | $100K–$500K | SH |
| TRVI | TREVI THERAPEUTICS INC | 21K | $100K–$500K | SH |
| FTRE | FORTREA HOLDINGS INC | 15K | $100K–$500K | SH |
| AGIO | AGIOS PHARMACEUTICALS INC | 10K | $100K–$500K | SH |
| VNET | VNET GROUP INC-ADR | 30K | $100K–$500K | SH |
| ZTS | ZOETIS INC | 2K | $100K–$500K | SH |
| TSHA | TAYSHA GENE THERAPIES INC | 45K | $100K–$500K | SH |
| INVA | INNOVIVA INC | 12K | $100K–$500K | SH |
| QURE | UNIQURE NV | 10K | $100K–$500K | SH |
| KOD | KODIAK SCIENCES INC | 9K | $100K–$500K | SH |
| PGEN | PRECIGEN INC | 58K | $100K–$500K | SH |
| RMD | RESMED INC | 1K | $100K–$500K | SH |
| ORKA | ORUKA THERAPEUTICS INC | 8K | $100K–$500K | SH |
| UPB | UPSTREAM BIO INC | 9K | $100K–$500K | SH |
| RLAY | RELAY THERAPEUTICS INC | 28K | $100K–$500K | SH |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 5K | $100K–$500K | SH |
| ALV | AUTOLIV INC | 2K | $100K–$500K | SH |
| NVCR | NOVOCURE LTD | 18K | $100K–$500K | SH |
| ARDX | ARDELYX INC | 40K | $100K–$500K | SH |
| TYRA | TYRA BIOSCIENCES INC | 9K | $100K–$500K | SH |
| AMLX | AMYLYX PHARMACEUTICALS INC | 18K | $100K–$500K | SH |
| DFTX | DEFINIUM THERAPEUTICS INC | 16K | $100K–$500K | SH |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 27K | $100K–$500K | SH |
| SIVR | ABRDN PHYSICAL SILVER SHARES | 3K | $100K–$500K | SH |
| XPEV | XPENG INC - ADR | 10K | $100K–$500K | SH |
| AMPH | AMPHASTAR PHARMACEUTICALS IN | 7K | $100K–$500K | SH |
| SVRA | SAVARA INC | 33K | $100K–$500K | SH |
| VTYX | VENTYX BIOSCIENCES INC | 22K | $100K–$500K | SH |
| TNGX | TANGO THERAPEUTICS INC | 22K | $100K–$500K | SH |
| PHAT | PHATHOM PHARMACEUTICALS INC | 12K | $100K–$500K | SH |
| SPRY | ARS PHARMACEUTICALS INC | 16K | $100K–$500K | SH |
| INBX | INHIBRX BIOSCIENCES INC | 2K | $100K–$500K | SH |
| GRFS | GRIFOLS SA-ADR | 20K | $100K–$500K | SH |